NMS Labs is a bioanalytical toxicology laboratory that stands out as a leader in esoteric clinical and forensic services. Since its establishment in 1970, NMS Labs has been dedicated to setting the standard for excellence in clinical toxicology and forensic testing. The company caters to the needs of healthcare providers, medical researchers, coroners, and the criminal justice system by offering state-of-the-art tests that other labs are unable to provide. NMS Labs boasts a wide scope of tests, remarkable accuracy of results, client service, scientific expertise, and innovation in various areas including forensic toxicology and criminalistics, clinical toxicology and esoteric testing, clinical research support, and expert consultative services. With its last investment being a $12.27M Venture Round investment on 04 November 2020, NMS Labs operates from its headquarters in the United States, and successfully caters to over 2,000 clients worldwide each year with the help of a team of more than 250 highly trained professionals. Whether standardized or unique testing is required, NMS Labs consistently delivers timely and authoritative results capable of withstanding even the most rigorous judicial and scientific review.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $12.27M | - | 04 Nov 2020 |
No recent news or press coverage available for NMS Labs.